StockNews.com initiated coverage on shares of Aware (NASDAQ:AWRE – Get Free Report) in a research note issued on Tuesday. The firm set a “buy” rating on the software maker’s stock.
Aware Stock Performance
Shares of NASDAQ AWRE traded down $0.03 during trading hours on Tuesday, hitting $1.75. 169,799 shares of the stock were exchanged, compared to its average volume of 51,912. The company’s fifty day simple moving average is $2.16 and its two-hundred day simple moving average is $1.96. The company has a market cap of $36.90 million, a PE ratio of -5.30 and a beta of 0.81. Aware has a 1-year low of $1.05 and a 1-year high of $2.97.
Aware (NASDAQ:AWRE – Get Free Report) last posted its quarterly earnings results on Thursday, August 8th. The software maker reported ($0.05) earnings per share for the quarter. The company had revenue of $4.32 million during the quarter. Aware had a negative net margin of 26.49% and a negative return on equity of 9.01%.
Institutional Investors Weigh In On Aware
Aware Company Profile
Aware, Inc, an authentication company, provides biometrics software products and solutions for government agencies and commercial entities in the United States, the United Kingdom, and internationally. The company offers biometric software solution, including Knomi, a mobile biometric framework which provides multiple biometric modality options; AwareABIS, an automated biometric identification system used for large-scale biometric identification and deduplication; AFIX suite used for small-scale law enforcement focused biometric identification; and AFIX Tracker for fingerprint, palmprint, and latent print identification, as well as AFIX Face, AFIX Verifier, AFIX Identifier, AFIX Comparator, AFIX Engine, and AFIX NIST Transaction Engine.
Featured Stories
- Five stocks we like better than Aware
- What is Put Option Volume?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- There Are Different Types of Stock To Invest In
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Aware Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aware and related companies with MarketBeat.com's FREE daily email newsletter.